| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MEDWELLAI Aktie jetzt für 0€ handeln | |||||
| 06.05. | MedWellAI Inc.: MedWell Ai, Inc Reports Q3 Revenues Of $618,676 And Provides Corporate Update | 185 | GlobeNewswire (Europe) | CLEARWATER, Fla., May 06, 2026 (GLOBE NEWSWIRE) -- via IBN -- MedWell Ai, Inc, (OTCQB:MWAI) ("Company") is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals... ► Artikel lesen | |
| 05.05. | MedWellAI, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 17.04. | MedWellAI, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 08.04. | Apollo Biowellness, Inc.: Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc. | 307 | Newsfile | North Bergen, New Jersey--(Newsfile Corp. - April 8, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company" or "Apollo"), in conjunction with the final due diligence being reviewed by MedwellAI... ► Artikel lesen | |
| 23.02. | MedWellAI, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 23.02. | MedWellAI, Inc.: MedWell Ai Reports Strong Q2 Revenues Of $548,315 And Provides Guidance For Full Year 2025 Exceeding $2,200,000 | 204 | GlobeNewswire (Europe) | CLEARWATER, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- MedWell Ai, Inc, (OTCQB:MWAI) ("Company") is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals... ► Artikel lesen | |
| 18.02. | MedWellAI, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 2 | SEC Filings | ||
| 10.02. | MedWellAI, Inc.: MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System | 101 | GlobeNewswire (Europe) | CLEARWATER, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- via IBN - MedWell Ai, Inc ("Company") (OTCQB: MWAI) is pleased to announce the signing of a Letter of Intent ("LOI") to create a vertically integrated... ► Artikel lesen | |
| 24.06.25 | MedWellAi, Inc. Completes Corporate Rebranding And Transformation Into Ai-Driven Healthcare and Wellness | 293 | PR Newswire | CLEARWATER, Fla., June 24, 2025 /PRNewswire/ -- MedWell Ai, Inc, (New Symbol/OTCQB: MWAI) is pleased to provide this Corporate Update, outlining company's new... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 37,260 | +1,61 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
01.06.2026 / 13:38... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 57,37 | -0,05 % | BrightSpring Health Services, Inc. - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 34,840 | +0,55 % | Mentice AB: Mentice and Siemens Healthineers Announce Co-Marketing Partnership to Advance Neurovascular Treatment Planning | Gothenburg, Sweden - June 2026 - Mentice AB, a global leader in simulation and clinical decision support solutions for Image-Guided Therapies, today announced a co-marketing agreement with Siemens Healthineers... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,180 | +1,17 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 15,380 | +0,07 % | Alignment Healthcare Named to the Fortune 1000 2026 List for Second Consecutive Year | ||
| GENEDX | 52,26 | +0,10 % | Sema4.ai's autonomous agent building platform gets simpler to use, adds deeper business context and more | ||
| BILLIONTOONE | 97,20 | +0,01 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| PROGYNY | 25,850 | -0,04 % | Progyny, Inc.: New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System | ||
| ONCOLOGY INSTITUTE | 4,870 | 0,00 % | Oncology Institute, Inc. - 8-K, Current Report | ||
| CARL ZEISS MEDITEC | 26,740 | +0,38 % | Aktien - Shortseller-Positionen: Carl Zeiss Meditec, Evotec, HelloFresh, Kontron, LPKF Laser, TeamViewer | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| VIVOS THERAPEUTICS | 0,856 | -1,04 % | Vivos Therapeutics, Inc: Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing | LITTLETON, Colo., June 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 27,850 | +0,07 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| UNITEDHEALTH | 346,20 | -0,17 % | UnitedHealth: "Kaufen" - startet die Aktie jetzt durch? | Die Aktie von UnitedHealth könnte nach Einschätzung der Bank of America vor einer weiteren Aufwärtsbewegung stehen. Die Analysten haben ihre Einstufung für den US-Krankenversicherer von "Neutral" auf... ► Artikel lesen | |
| ALPHA TAU MEDICAL | 9,360 | +0,11 % | Alpha Tau Medical Ltd.: Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting | - Results reinforce the potential feasibility and safety of Alpha DaRT as a one-time, minimally invasive intratumoral treatment that fits naturally into the patient journey - - Pooled analysis of... ► Artikel lesen | |
| HEARTFLOW | 28,110 | +0,04 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen |